|
Dec 1
|
Top Penny Stocks for Q4 2023
|
|
Nov 8
|
Myomo, Inc. (AMEX:MYO) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations
|
|
Nov 6
|
CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting
|
|
Nov 2
|
Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category
|
|
Aug 25
|
Myomo Announces Pricing of $4.4 Million Public Offering
|
|
Aug 24
|
Myomo Inc (MYO): A Hidden Gem or a Potential Value Trap?
|
|
Aug 24
|
Myomo, Inc. Announces Proposed Public Offering
|
|
Aug 24
|
Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims
|
|
Aug 21
|
Myomo Announces Two German Social Court Rulings Ordering MyoPro® Reimbursement
|
|
Aug 9
|
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 9
|
Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics
|
|
May 3
|
Myomo to Report First Quarter Financial Results on May 10, 2023
|